Analgesics of the Future

Dr. Stanley Golovac discusses the importance of innovation in analgesics. Dr. Golovac makes several suggestions, including shifting from VAS scores to measures of functionality, use of alternative analgesics, and the need for new, evidence-based guidelines for opioid prescribing.

He highlights a study demonstrating that inhibition of the endogenous receptor tyrosine kinase EGFR can significantly reduce chronic neuropathic pain and suggests other potential targets for alternative therapies.